| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $168.9M | — | -4.8% |
| Cost of Revenue | $159.2M | — | +0.5% |
| R&D Expense | $8.7M | — | -17.0% |
| SG&A Expense | $26.8M | — | -52.8% |
| Operating Income | -$57.4M | — | +29.0% |
| Pre-tax Income | -$82.4M | — | +16.9% |
| Income Tax | $509K | — | +552.6% |
| Net Income | -$83.0M | — | +16.5% |
| EPS (Basic) | -$2.29 | — | -1535.7% |
| EPS (Diluted) | -$2.29 | — | -1535.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $54.1M | -59.6% | -68.5% |
| Accounts Receivable | $32.3M | +33.3% | -22.7% |
| Inventory | $2.2M | -80.9% | -82.6% |
| Current Assets | $164.8M | -33.9% | -44.9% |
| Total Assets | $916.2M | -5.4% | -16.0% |
| Current Liabilities | $854.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$99.6M | — | -107.9% |
| Capital Expenditures | $62.4M | — | +324.1% |
| Investing Cash Flow | -$38.7M | — | -339.9% |
| Financing Cash Flow | $63.4M | — | +830.2% |
| Free Cash Flow | -$162.0M | — | -158.7% |
| -7.7% |
| Long-term Debt | $749.0M | +11.6% | -2.2% |
| Total Liabilities | $1.38B | +1.5% | +0.8% |
| Stockholders' Equity | -$465.7M | -18.8% | -61.6% |